CIM
ABBV icon

Chiron Investment Management’s AbbVie ABBV Stock Holding History

Chiron Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,752
Closed -$2.12M – 87
2024
Q3 		$2.12M Buy
+10,752
New +$2.01M 0.75% 38
2023
Q4 		– Sell
-44,625
Closed -$6.65M – 89
2023
Q3 		$6.65M Buy
+44,625
New +$6.55M 2.81% 12
2023
Q2 		– Sell
-223
Closed -$35.5K – 124
2023
Q1 		$35.5K Hold
223
– – 0.01% 124
2022
Q4 		$36K Sell
223
-10,097
-98% -$1.55M 0.01% 121
2022
Q3 		$1.39M Buy
+10,320
New +$1.48M 0.28% 43
2018
Q3 		– Sell
-208,202
Closed -$19.3M – 70
2018
Q2 		$19.3M Buy
208,202
+4,431
+2% +$433K 1.33% 37
2018
Q1 		$19.3M Buy
203,771
+8,285
+4% +$910K 1.68% 34
2017
Q4 		$18.9M Buy
195,486
+73,200
+60% +$6.9M 2.56% 24
2017
Q3 		$10.9M Buy
122,286
+22,685
+23% +$1.73M 2.29% 19
2017
Q2 		$7.22M Sell
99,601
-5,800
-6% -$390K 2.14% 22
2017
Q1 		$6.87M Buy
105,401
+42,800
+68% +$2.69M 2.61% 17
2016
Q4 		$3.92M Buy
+62,601
New +$3.82M 2.72% 15

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Chiron Investment Management's ABBV Position: Q4 2024 in Review

Chiron Investment Management sold out of AbbVie (ABBV) in Q4 2024, closing a stake of 10,752 shares — an estimated $2.12M sold.

Chiron Investment Management first reported a position in ABBV in Q4 2016 and held it in 12 quarters. The position peaked at $19.3M in Q2 2018. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Chiron Investment Management reported no remaining AbbVie position as of Q4 2024 after selling out during the quarter.
  • Chiron Investment Management sold 10,752 AbbVie shares in Q4 2024, an estimated $2.12M.
  • Chiron Investment Management first reported a position in AbbVie in Q4 2016 and held it in 12 quarters.
  • Chiron Investment Management's AbbVie position peaked at $19.3M in Q2 2018.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Chiron Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.